{
  "healthImplications": {
    "shortTerm": {
      "sleepDisruption": 80,
      "nutritionalImpact": 60,
      "physicalDiscomfort": 70,
      "psychologicalImpact": 50,
      "healthRisk": 30
    },
    "longTerm": {
      "sleepDisruption": 50,
      "nutritionalImpact": 75,
      "physicalDiscomfort": 45,
      "psychologicalImpact": 60,
      "healthRisk": 80
    },
    "qualityOfLife": {
      "sleepDisruption": 75,
      "dietaryRestrictions": 60,
      "physicalDiscomfort": 50,
      "psychologicalImpact": 40
    },
    "associatedRisks": [
      {
        "condition": "Malabsorption",
        "riskLevel": "Moderate",
        "description": "May worsen existing vitamin deficiencies (B12, D)"
      },
      {
        "condition": "Fatty Liver Progression",
        "riskLevel": "High",
        "description": "Gut dysbiosis linked to NAFLD progression"
      },
      {
        "condition": "Systemic Inflammation",
        "riskLevel": "Moderate",
        "description": "Chronic gut dysbiosis can contribute to inflammation"
      },
      {
        "condition": "Intestinal Permeability",
        "riskLevel": "Moderate",
        "description": "Can trigger immune responses and food sensitivities"
      },
      {
        "condition": "Microbiome Disruption",
        "riskLevel": "High",
        "description": "Long-term dysbiosis can permanently alter gut microbiota"
      }
    ]
  },
  "medicationAnalysis": {
    "rifaximin": {
      "safetyRatings": {
        "overallSafety": 90,
        "sideEffectRisk": 85,
        "longTermUseSafety": 80,
        "drugInteractionRisk": 95
      },
      "effectiveness": {
        "hydrogenSIBO": 85,
        "methaneSIBO": 60,
        "hydrogenSulfideSIBO": 50
      }
    },
    "ganaton": {
      "safetyRatings": {
        "overallSafety": 80,
        "sideEffectRisk": 75,
        "longTermUseSafety": 85,
        "drugInteractionRisk": 80
      }
    },
    "librax": {
      "safetyRatings": {
        "overallSafety": 60,
        "sideEffectRisk": 50,
        "longTermUseSafety": 40,
        "drugInteractionRisk": 55
      },
      "sideEffects": [
        {"effect": "Drowsiness", "probability": "High"},
        {"effect": "Dry Mouth", "probability": "High"},
        {"effect": "Blurred Vision", "probability": "Moderate"},
        {"effect": "Constipation", "probability": "Moderate"},
        {"effect": "Dependence", "probability": "Low-Moderate"}
      ]
    },
    "econorm": {
      "safetyRatings": {
        "overallSafety": 95,
        "sideEffectRisk": 90,
        "longTermUseSafety": 95,
        "drugInteractionRisk": 98
      }
    },
    "comparison": {
      "rifaximin": {
        "effectiveness": 90,
        "safety": 85,
        "cost": 50,
        "convenience": 80,
        "longTermUse": 75
      },
      "ganaton": {
        "effectiveness": 70,
        "safety": 80,
        "cost": 70,
        "convenience": 85,
        "longTermUse": 80
      },
      "librax": {
        "effectiveness": 65,
        "safety": 60,
        "cost": 65,
        "convenience": 90,
        "longTermUse": 40
      },
      "econorm": {
        "effectiveness": 60,
        "safety": 95,
        "cost": 75,
        "convenience": 95,
        "longTermUse": 90
      }
    }
  },
  "scientificResearch": {
    "siboSubtypes": {
      "hydrogenPredominant": 40,
      "methanePredominant": 30,
      "hydrogenSulfidePredominant": 15,
      "mixedType": 15
    },
    "keyFindings": [
      {
        "finding": "IBS-C associated with higher breath methane levels",
        "researcher": "Pimentel et al.",
        "year": 2020,
        "implication": "Methane-targeted antibiotics for constipation-predominant IBS"
      },
      {
        "finding": "Post-infectious etiology of IBS and SIBO",
        "researcher": "Pimentel et al.",
        "year": 2017,
        "implication": "Blood tests for anti-CdtB and anti-vinculin antibodies"
      },
      {
        "finding": "Hydrogen sulfide as a third gas in SIBO",
        "researcher": "Rezaie et al.",
        "year": 2022,
        "implication": "Trio-Smart breath test for comprehensive diagnosis"
      },
      {
        "finding": "Impaired MMC function in SIBO patients",
        "researcher": "Takakura & Pimentel",
        "year": 2020,
        "implication": "Prokinetics to prevent SIBO recurrence"
      },
      {
        "finding": "Rifaximin efficacy for IBS-D",
        "researcher": "Pimentel et al.",
        "year": 2011,
        "implication": "FDA approval of Rifaximin for IBS-D"
      }
    ]
  },
  "dietaryInterventions": {
    "comparison": {
      "lowFODMAP": {
        "effectiveness": 75,
        "difficulty": 60,
        "scientificEvidence": 85
      },
      "specificCarbohydrateDiet": {
        "effectiveness": 70,
        "difficulty": 75,
        "scientificEvidence": 70
      },
      "lowSulfurDiet": {
        "effectiveness": 65,
        "difficulty": 65,
        "scientificEvidence": 50
      },
      "elementalDiet": {
        "effectiveness": 90,
        "difficulty": 95,
        "scientificEvidence": 80
      }
    }
  },
  "lifestyleModifications": {
    "impact": {
      "sleepOptimization": 85,
      "stressManagement": 80,
      "physicalActivity": 70,
      "mealTiming": 75,
      "hydration": 65
    }
  },
  "treatmentProgress": {
    "timeline": {
      "week1": 10,
      "week2": 30,
      "week4": 50,
      "week8": 70,
      "week12": 80,
      "week24": 90
    }
  }
}
